Investment Summary

1315 Capital, Ampersand Capital Partners and The BroadOak Fund Invest In Interpace

On January 13, 2020, growth capital firms 1315 Capital, Ampersand Capital Partners and The BroadOak Fund invested in life science company Interpace

Investment Highlights
  • This is 1315 Capital’s 3rd, Ampersand Capital Partners’ 25th and The BroadOak Fund’s 7th transaction in the Life Science sector.
  • This is 1315 Capital’s 11th, Ampersand Capital Partners’ 51st and The BroadOak Fund’s 9th transaction in the United States.
  • This is 1315 Capital’s 2nd, Ampersand Capital Partners’ 6th and The BroadOak Fund’s 1st transaction in New Jersey.

Investment Summary

Date 2020-01-13
Target Interpace
Sector Life Science
Investor(s) 1315 Capital
Ampersand Capital Partners
The BroadOak Fund
Deal Type Stake Purchase

Target

Interpace

Parsippany, New Jersey, United States
Interpace engages in enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Interpace Biosciences was founded in 1986 and is based in Parsippany, New Jersey.

Search 214,876 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 3

DESCRIPTION

1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The Firm will consider opportunities across the US and generally looks to commit $10 to $40 million per investment. 1315 Capital was formed in 2014 and is based in Philadelphia, Pennsylvania.


DEAL STATS #
Overall 13 of 22
Sector: Life Science M&A 3 of 6
Type: Stake Purchase M&A Deals 2 of 2
State: New Jersey M&A 2 of 3
Country: United States M&A 11 of 20
Year: 2020 M&A 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-17 Greenbrook TMS

Toronto, Ontario, Canada

Greenbrook TMS is a provider of TMS Therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook TMS was founded in 2011 and is based in Toronto, Ontario.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-02-10 Centurion Service Group

Franklin Park, Illinois, United States

Centurion Service Group partners with hospitals and surgery centers to unlock and extend the value of their surplus medical equipment. Centurion provides a hassle-free, full-cycle, service-focused solution: Centurion Service Group works with hospitals to create strategies for surplus equipment liquidation; to pick up, transport, warehouse, and sell surplus devices, and to continue the value of surplus equipment by turning it into new equipment, refurbished equipment or essential services. Centurion Service Group is a major medical equipment life-cycle company with extensive warehousing, auction and logistical footprint in the United States. Centurion Service Group was founded in 2001 and is based in Franklin Park, Illinois.

Buy -
Investor

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1988
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.


DEAL STATS #
Overall 54 of 86
Sector: Life Science M&A 25 of 43
Type: Stake Purchase M&A Deals 1 of 2
State: New Jersey M&A 6 of 7
Country: United States M&A 51 of 70
Year: 2020 M&A 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-04 Canopy Biosciences

St. Louis, Missouri, United States

Canopy Biosciences LLC is a provider of gene editing and gene expression products and services. Canopy's gene-editing portfolio spans easy-to-use CRISPR kits, off-the-shelf cell lines, as well as full-service custom cell line engineering. Canopy Biosciences was founded in 2016 and is based in St. Louis, Missouri.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-04-21 Tjoapack

Etten-Leur, Netherlands

Tjoapack is a contract packager of medicines servicing clients across five continents and 42 countries. The CPO specializes in primary packaging for solid dosage forms, secondary packaging, and unit dose packaging and now has a total of 19 packaging lines for blisters, wallets, and bottles. Tjoapack was founded in 1989 and is based in Etten-Leur, Netherlands.

Buy -
DESCRIPTION

The BroadOak Fund is the investment affiliate of life science focused investment bank BroadOak Capital Partners. The BroadOak Fund provides growth capital to life sciences tools and service providers that have achieved a level of commercial success. The BroadOak Fund is based in Bethesda, Maryland.


DEAL STATS #
Overall 9 of 26
Sector: Life Science M&A 7 of 21
Type: Stake Purchase M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 9 of 24
Year: 2020 M&A 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-14 Particle Dynamics

Saint Louis, Missouri, United States

Particle Dynamics engages in particle processing technologies and finished dose manufacturing, providing a wide range of products and services to the nutraceutical, consumer health, OTC, and pharmaceutical sectors. Particle Dynamics is also a recognized global leader in the supply of highly functional materials and a variety of microencapsulated vitamins, minerals, and OTC active pharmaceutical ingredients. Particle Dynamics was founded in 1990 and is based in Saint Louis, Missouri.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-14 seqWell

Beverly, Massachusetts, United States

seqWell provides multiplexed solution for preparing NGS libraries from hundreds to thousands of samples without normalization or additional equipment. seqWell is based in Beverly, Massachusetts.

Buy -